Depomed Sues Cadila, Zydus Over Generic Gralise
By Megan Leonhardt ( May 11, 2012, 12:11 PM EDT) -- Drug company Depomed Inc. lodged a patent infringement suit Wednesday in New Jersey in an effort to block plans by Indian drugmaker Cadila Healthcare Ltd. and its U.S. subsidiary to market a generic version of epilepsy medication Gralise....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.